Mira Pharmaceuticals, Inc. (MIRA) SEC Filings — 2024

Filings

• Mira Pharmaceuticals Appoints BDO USA as New Auditor — 8-K · Dec 20, 2024
• Mira Pharmaceuticals Files 8-K — 8-K · Dec 19, 2024
• Mira Pharmaceuticals Files 8-K — 8-K · Dec 10, 2024
• Mira Pharmaceuticals Announces Board and Executive Changes — 8-K · Nov 21, 2024
• Mira Pharmaceuticals to Acquire BioGenetics — 8-K · Nov 19, 2024
• Mira Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
• Mira Pharmaceuticals to Acquire Private Company — 8-K · Oct 25, 2024
• Mira Pharmaceuticals Files 8-K — 8-K · Oct 21, 2024
• Mira Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Sep 12, 2024
• Mira Pharmaceuticals Updates Corporate Address and Phone — 8-K · Sep 10, 2024
• Mira Pharmaceuticals Files 8-K: $1.5M Stock Sale & Nasdaq Bid Price Notice — 8-K · Aug 23, 2024
• Mira Pharmaceuticals Files Q2 2024 10-Q Amendment — 10-Q/A · Aug 16, 2024
• Mira Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
• Mira Pharmaceuticals to Acquire BioGenetics, Inc. — 8-K · Aug 9, 2024
• Mira Pharmaceuticals Relocates Principal Executive Offices — 8-K · Aug 8, 2024
• MIRA Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Jul 26, 2024
• Mira Pharmaceuticals to Acquire BioGenetics, Inc. — 8-K · Jul 24, 2024
• Mira Pharmaceuticals to Acquire Bio-Genetics, Inc. — 8-K · Jul 19, 2024
• Mira Pharmaceuticals Faces Nasdaq Delisting Concerns — 8-K · Jul 12, 2024
• Mira Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Jun 28, 2024
• Mira Pharmaceuticals Adds New Director, Dr. Jianjun Li — 8-K · May 29, 2024
• Mira Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Mira Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
• Mira Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Mar 13, 2024
• Mira Pharmaceuticals to Acquire NovaLead Pharma — 8-K · Mar 7, 2024
• MIRA PHARMACEUTICALS: Leadership & Compensation Changes Reported — 8-K · Jan 17, 2024